5. Wash your hands right away after applying MIRVASO topical gel.
• Store MIRVASO topical gel at room temperature between 68°F to 77°F (20°C to 25°C).
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Made in Canada.
NDC 0299-5980-30 Rx Only
MIRVASO®
(brimonidine) topical gel, 0.33%*
*Each gram of Mirvaso topical gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base
NET WT. 30 g
For Topical Use Only
Keep Out of Reach of Children
GALDERMA
Marketed by:
GALDERMA LABORATORIES, L.P.
14501 North Freeway, Forth Worth, TX 76177 USA
Made in Canada
P51218-0 Rev.: 08/13
Not for oral, ophthalmic or intravaginal use.
To Open Tube: Push cap in and turn counterclockwise, a quarter of a turn, and remove cap.
Usual Dosage: Apply a small pea-sized amount once daily to each of the five areas of the face (forehead, chin, nose, and each cheek) avoiding the eyes and lips. See package insert for complete prescribing information.
Each gram contains the active ingredient brimonidine tartrate 5mg with the inactive ingredients carbomer homoploymer type B, glycerin, methylparaben, phenoxyethanol, propylene glycol, purified water, sodium hydroxide, and titanium dioxide.
Storage: Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). (See USP Controlled Room Temperature)
See carton closure for lot number and expiration date.
